CLS is a rare X-linked semidominant neurodevelopmental condition caused by pathogenic variants in RPS6KA3, encoding the ribosomal S6 kinase 2 (RSK2) protein (Hahn and Hanauer, 2012; Kentab, 2017). Here, RPS6KA3 is linked to Coffin-Lowry syndrome.